@inproceedings{inproceedings, title = {{DUPILUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN ATOPIC DERMATITIS PATIENTS INADEQUATELY CONTROLLED, INTOLERANT, OR INADVISABLE FOR CYCLOSPORINE-A}}, url = {{}}, year = {{2017}}, month = {{1}}, author = {{De Bruin-Weller M and Gadkari A and Simpson E and Cork M and Puig L and Girolomoni G and Wollenberg A and Chen Z and Radin A and Shumel B and Ardeleanu M et al}}, volume = {{119}}, journal = {{ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY}}, issue = {{5}}, pages = {{S94-S95}}, note = {{Accessed on 2025/05/22}}}